公开(公告)号：US11707220B2

公开(公告)日：2023-07-25

申请号：US16885574

申请日：2020-05-28

Applicant: Medtronic Ardian Luxembourg S.a.r.l.

Inventor： Douglas Hettrick ,  Shantanu Sarkar

IPC: A61B5/00 ,  G16H50/30 ,  G16H50/20 ,  A61B5/0245 ,  A61N1/36 ,  A61B18/14 ,  G16H20/40 ,  G16H20/30 ,  A61B18/00 ,  A61B18/02 ,  A61B5/024 ,  A61B5/053 ,  A61N7/02 ,  A61B34/00 ,  G16H20/17 ,  A61B5/349

CPC classification number: A61B5/4035 ,  A61B5/0245 ,  A61B18/1492 ,  A61N1/36017 ,  G16H20/30 ,  G16H20/40 ,  G16H50/20 ,  G16H50/30 ,  A61B5/00 ,  A61B5/02405 ,  A61B5/053 ,  A61B5/349 ,  A61B5/4836 ,  A61B2018/00404 ,  A61B2018/00434 ,  A61B2018/00511 ,  A61B2018/00773 ,  A61B2018/00839 ,  A61B2018/00875 ,  A61B2018/0212 ,  A61B2018/0262 ,  A61B2018/1435 ,  A61B2034/256 ,  A61N7/022 ,  G16H20/17

Abstract: Systems and methods for assessing sympathetic nervous system (SNS) tone for renal neuromodulation therapy are disclosed herein. A system configured in accordance with embodiments of the present technology can include, for example, a detector attached to or implanted in a patient and a receiver communicatively coupled to the detector. The detector can measure cardiac data and the receiver and/or a device communicatively coupled thereto can analyze the cardiac data to provide one or more SNS tone indicators. The SNS tone indicators can be used to determine whether a patient will be responsive to a neuromodulation therapy and/or whether a neuromodulation therapy was effective.

公开(公告)号：US10667736B2

公开(公告)日：2020-06-02

申请号：US15526472

申请日：2015-12-17

Applicant: Medtronic Ardian Luxembourg S.a.r.l.

Inventor： Douglas Hettrick ,  Shantanu Sarkar

IPC: A61B5/00 ,  A61B18/14 ,  A61B5/0245 ,  A61N1/36 ,  A61B18/00 ,  G16H50/30 ,  G16H50/20 ,  G06F19/00 ,  A61B18/02 ,  A61B5/024 ,  A61B5/0452 ,  A61B5/053 ,  A61N7/02 ,  A61B34/00

Abstract: Systems and methods for assessing sympathetic nervous system (SNS) tone for renal neuromodulation therapy are disclosed herein. A system configured in accordance with embodiments of the present technology can include, for example, a detector attached to or implanted in a patient and a receiver communicatively coupled to the detector. The detector can measure cardiac data and the receiver and/or a device communicatively coupled thereto can analyze the cardiac data to provide one or more SNS tone indicators. The SNS tone indicators can be used to determine whether a patient will be responsive to a neuromodulation therapy and/or whether a neuromodulation therapy was effective.